WO2003029290A1 - Transporteur de medicament et son utilisation - Google Patents

Transporteur de medicament et son utilisation Download PDF

Info

Publication number
WO2003029290A1
WO2003029290A1 PCT/JP2002/009960 JP0209960W WO03029290A1 WO 2003029290 A1 WO2003029290 A1 WO 2003029290A1 JP 0209960 W JP0209960 W JP 0209960W WO 03029290 A1 WO03029290 A1 WO 03029290A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug transporter
transporter activity
protein
drug
seq
Prior art date
Application number
PCT/JP2002/009960
Other languages
English (en)
French (fr)
Inventor
Akio Fujimura
Shuichi Tsuruoka
Kenichi Ishibashi
Masashi Imai
Osamu Ohara
Takahiro Nagase
Original Assignee
Proteinexpress Co., Ltd.
Kazusa Dna Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteinexpress Co., Ltd., Kazusa Dna Research Institute filed Critical Proteinexpress Co., Ltd.
Priority to EP02800251A priority Critical patent/EP1437363A4/en
Priority to JP2003532535A priority patent/JP3994088B2/ja
Priority to US10/491,226 priority patent/US20050014152A1/en
Publication of WO2003029290A1 publication Critical patent/WO2003029290A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PCT/JP2002/009960 2001-09-28 2002-09-26 Transporteur de medicament et son utilisation WO2003029290A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02800251A EP1437363A4 (en) 2001-09-28 2002-09-26 MEDICINAL TRANSPORT AND USE THEREOF
JP2003532535A JP3994088B2 (ja) 2001-09-28 2002-09-26 薬物トランスポーター及びその用途
US10/491,226 US20050014152A1 (en) 2001-09-28 2002-09-28 Drug transporter and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001302830 2001-09-28
JP2001-302830 2001-09-28

Publications (1)

Publication Number Publication Date
WO2003029290A1 true WO2003029290A1 (fr) 2003-04-10

Family

ID=19123013

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/009960 WO2003029290A1 (fr) 2001-09-28 2002-09-26 Transporteur de medicament et son utilisation

Country Status (4)

Country Link
US (1) US20050014152A1 (ja)
EP (1) EP1437363A4 (ja)
JP (1) JP3994088B2 (ja)
WO (1) WO2003029290A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013039065A (ja) * 2011-08-12 2013-02-28 Nagasaki Univ 自己炎症疾患又は自己免疫疾患関連遺伝子及びその利用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999053045A1 (en) * 1998-04-09 1999-10-21 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2002012340A2 (en) * 2000-08-03 2002-02-14 Incyte Genomics, Inc. Transporters and ion channels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866420A (en) * 1993-10-08 1999-02-02 The United States Of America As Represented By The Secretary Of Agriculture Artificial liver device
US6150164A (en) * 1996-09-30 2000-11-21 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
JP2003505095A (ja) * 1999-07-23 2003-02-12 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド Ａｂｃトランスポートポリヌクレオチド、ポリペプチド、および抗体
EP1217066A1 (en) * 2000-12-21 2002-06-26 Universiteit Gent Modulation of ATP-binding cassette transporter activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999053045A1 (en) * 1998-04-09 1999-10-21 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2002012340A2 (en) * 2000-08-03 2002-02-14 Incyte Genomics, Inc. Transporters and ion channels

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
IIDA A. ET AL: "Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5 and ABCG8", J. HUM. GENET., vol. 47, no. 6, June 2002 (2002-06-01), pages 285 - 310, XP002966806 *
See also references of EP1437363A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013039065A (ja) * 2011-08-12 2013-02-28 Nagasaki Univ 自己炎症疾患又は自己免疫疾患関連遺伝子及びその利用

Also Published As

Publication number Publication date
EP1437363A4 (en) 2006-03-30
EP1437363A1 (en) 2004-07-14
JP3994088B2 (ja) 2007-10-17
JPWO2003029290A1 (ja) 2005-01-13
US20050014152A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
IL210454A (en) Antibody against a new ligand of cytokine 17zcytor
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
IL123164A (en) Meta-guanidine urea thiourea or azacyclic amino benzoic acid derivatives and pharmaceutical compositions containing them
AU4710499A (en) Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
WO2005049078A3 (en) Immunoglobulin preparations having increased stability
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
WO1999059609A3 (en) Use of hmg proteins for the preparation of medicaments having cytotoxic activity
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO2004082629A3 (en) Novel cyclosporins
WO2003059323A3 (de) Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren ii
WO2003029290A1 (fr) Transporteur de medicament et son utilisation
WO2000078956A8 (en) Novel pyrrhocoricin-derived peptides, and methods of use thereof
EP1023906A4 (en) AMPLIFIER FOR ANTIBODY AGAINST LYMPHOIDEN TUMOR
EP1310490A4 (en) GPR14 ANTAGONIST
WO2002062944A2 (fr) Nouveau peptide physiologiquement actif et son utilisation
ITTO20010237A0 (it) Procedimento per la preparazione di un idrolizzato proteico utile perl'impiego come fertilizzante.
WO2001090139A3 (en) A ligand for enhancing oral and cns delivery of biological agents
WO2001092468A3 (en) Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof
WO2002061074A1 (fr) Nouvelle proteine et adn la comprenant
WO2003060516A1 (fr) Methode de criblage
WO2002029053A1 (fr) Nouvelle proteine de recepteur couple a la proteine g et adn correspondant
WO2003022300A1 (fr) Remedes prophylactiques et curatifs contre les maladies des os et des articulations
EP1455186A4 (en) SCREENING METHOD

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003532535

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002800251

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002800251

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10491226

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2002800251

Country of ref document: EP